OPEN END TURBO CALL-OPTIONSSCHEIN MIT SL - EDWARDS LIFESCIENCES | Market Closed - Börse Stuttgart 03:47:58 2024-07-16 pm EDT | ||
| 6.34 EUR | -2.31% |
|
| Current month | -8.51% | ||
| 1 month | -1.40% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
| Date | Price | Change |
|---|---|---|
| 24-07-16 | 6.34 | -2.31% |
| 24-07-15 | 6.49 | -2.84% |
| 24-07-12 | 6.68 | -3.19% |
| 24-07-11 | 6.9 | -0.72% |
| 24-07-10 | 6.95 | +0.29% |
Delayed Quote Börse Stuttgart
Last update July 16, 2024 at 03:47 pm EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SW1Z03 |
| ISIN | DE000SW1Z032 |
| Date issued | 2023-08-08 |
| Strike | 18.44 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 5.77 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 7.21 € |
|---|---|
| Lowest since issue | 4.11 € |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
87.73
USD
Average target price
96.46
USD
Spread / Average Target
+9.95%
- Stock Market
- Certificates
- Certificat
